Kraig Biocraft Labs Achieves Breakthrough in Spider Silk Production

Kraig Biocraft Laboratories has successfully completed its spring spider silk production trials in Denver, Colorado. The trials demonstrated the strongest and most resilient lines of recombinant spider silk hybrids, ready for rapid production expansion.

author-image
Bijay Laxmi
New Update
Kraig Biocraft Labs Achieves Breakthrough in Spider Silk Production

Kraig Biocraft Labs Achieves Breakthrough in Spider Silk Production

Kraig Biocraft Laboratories (OTCQB: KBLB) has successfully completed its spring spider silkproduction trialsin Denver, Colorado, marking a significant milestone in the company's mission to produce recombinant spider silks on a commercial scale. The trials, which were overseen by renowned sericulture expert Dr. Nirmal Kumar, exceeded expectations and demonstrated the strongest and most resilient lines Kraig Labs has ever developed.

Why this matters: The breakthrough in spider silk production has significant implications for the fibers industry, potentially revolutionizing the way textiles are manufactured. This innovation could lead to the development of stronger, more sustainable, and environmentally friendly materials, with far-reaching consequences for various industries and consumers alike.

The spring trials proved that Kraig Labs' BAM-1 recombinant spider silk hybrids are ready for rapid production expansion. Throughout the entire production cycle, no instances of disease or infection were detected, a result that surprised even local silkworm experts. The BAM-1 parental lines were further optimized during the trials, delivering larger cocoons with improved reeling characteristics and higher yields.

Dr. Nirmal Kumar expressed his satisfaction with the results, stating, "I am proud of the work accomplished and very impressed by the performance of the BAM-1 silkworm lines. The luster of the BAM-1 silk is very unique and desirable. When paired with its strength, we have created a silk that can't be matched. The results of these trials exceeded our expectations. We are now on a solid foundation to scale production of the BAM-1 hybrid to metric ton levels."

Kraig Biocraft Laboratories is pioneering the production of genetically bioengineered spider silk using silkworms modified to spin spider silk cocoons that can be harvested in commercial quantities. The company's successful spring trials position it for commercial-scale production of its recombinant spider silks, which could have significant implications for the fibers market.

The successful completion of the spring spider silk trials in Denver, Colorado, marks a majorbreakthroughfor Kraig Biocraft Laboratories. With the BAM-1 recombinant spider silk hybrids demonstrating their readiness for rapid production expansion and the company now positioned for commercial-scale production, Kraig Labs is poised to revolutionize the fibers industry with its innovative and sustainable spider silk technology.